Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Molecules (Basel, Switzerland)|November 27, 2021
Drug Design: Where We Are and Future ProspectsGiuseppe Zagotto, Marco Bortoli
RSC Advances|May 6, 2022
Fluoxetine scaffold to design tandem molecular antioxidants and green catalystsGiovanni Ribaudo, Marco Bortoli, Alberto Ongaro, et al.
Molecules (Basel, Switzerland)|June 2, 2021
Selenoxide Elimination Triggers Enamine Hydrolysis to Primary and Secondary Amines: A Combined Experimental and Theoretical InvestigationGiovanni Ribaudo, Marco Bortoli, Erika Oselladore, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 10, 2016
Mechanistic Insight into the Oxidation of Organic Phenylselenides by H2 O2Giovanni Ribaudo, Massimo Bellanda, Ileana Menegazzo, et al.
International Journal of Molecular Sciences|July 29, 2023
Antioxidant Chimeric Molecules: Are Chemical Motifs Additive? The Case of a Selenium-Based LigandDavide Zeppilli, Anna Aldinio-Colbachini, Giovanni Ribaudo, et al.
ACS Omega|March 21, 2022
ROS-Scavenging Selenofluoxetine Derivatives Inhibit In Vivo Serotonin ReuptakeGiovanni Ribaudo, Marco Bortoli, Colby E Witt, et al.
Computational and Structural Biotechnology Journal|March 15, 2019
Psychiatric Disorders and Oxidative Injury: Antioxidant Effects of Zolpidem Therapy disclosed In SilicoMarco Bortoli, Marco Dalla Tiezza, Cecilia Muraro, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|July 30, 2004
Development of DNA topoisomerase-related therapeutics: a short perspective of new challengesGiovanni Capranico, Giuseppe Zagotto, Manlio Palumbo
ACS Chemical Neuroscience|September 2, 2017
The Medicinal Chemistry of Natural and Semisynthetic Compounds against Parkinson's and Huntington's DiseasesEnrico Zanforlin, Giuseppe Zagotto, Giovanni Ribaudo
Pageof 11